Dennis Langer - 03 Aug 2021 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Nathan A. Smith For: Dennis H. Langer
Issuer symbol
MYGN
Transactions as of
03 Aug 2021
Net transactions value
-$280,800
Form type
4
Filing time
05 Aug 2021, 17:11:17 UTC
Previous filing
04 Jun 2021
Next filing
10 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Options Exercise $761,700 +30,000 +34% $25.39 119,527 03 Aug 2021 Direct F1
transaction MYGN Common Stock Sale $1,042,500 -30,000 -25% $34.75 89,527 03 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -30,000 -100% $0.000000* 0 03 Aug 2021 Common Stock 30,000 $25.39 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The shares subject to this option are fully vested and exercisable.